Journal
Proceedings of the National Academy of Sciences of the United States of America
Publication Date
11-2-2021
Volume
118
Issue
44
First Page
e2116147118
Document Type
Open Access Publication
DOI
10.1073/pnas.2116147118
Rights and Permissions
Novalia Pishesha, Thibault J. Harmand, Paul W. Rothlauf, Patrique Praest, Ryan K. Alexander, Renate van den Doel, Mariel J. Liebeskind, Maria A. Vakaki, Nicholas McCaul, Charlotte Wijne, Elisha Verhaar, William Pinney, Hailey Heston, Louis-Marie Bloyet, Marjorie Cornejo Pontelli, Ma. Xenia G. Ilagan, Robert Jan Lebbink, William J. Buchser, Emmanuel J. H. J. Wiertz, Sean P. J. Whelan, Hidde L. Ploegh (2021) A class II MHC-targeted vaccine elicits immunity against SARS-CoV-2 and its variants. Proceedings of the National Academy of Sciences, 118 (44): e2116147118. DOI: 10.1073/pnas.2116147118. This open access article is distributed under Creative Commons Attribution License 4.0 (CC BY).
Recommended Citation
Pishesha, Novalia; Rothlauf, Paul W; Liebeskind, Mariel J; Vakaki, Maria A; Bloyet, Louis-Marie; Pontelli, Marjorie Cornejo; Ilagan, Ma Xenia G; Buchser, William J; Whelan, Sean P J; and et al, "A class II MHC-targeted vaccine elicits immunity against SARS-CoV-2 and its variants." Proceedings of the National Academy of Sciences of the United States of America. 118, 44. e2116147118 (2021).
https://digitalcommons.wustl.edu/open_access_pubs/11017
Supplemental figures
